Efficacy of a povidone-iodine foam dressing (Betafoam) on diabetic foot ulcer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gwak, Heui C. | - |
dc.contributor.author | Han, Seung H. | - |
dc.contributor.author | Lee, Jinwoo | - |
dc.contributor.author | Park, Sejin | - |
dc.contributor.author | Sung, Ki-Sun | - |
dc.contributor.author | Kim, Hak-Jun | - |
dc.contributor.author | Chun, Dongil | - |
dc.contributor.author | Lee, Kyungmin | - |
dc.contributor.author | Ahn, Jae-Hoon | - |
dc.contributor.author | Kwak, Kyunghee | - |
dc.contributor.author | Chung, Hyung-Jin | - |
dc.date.accessioned | 2021-08-31T11:29:40Z | - |
dc.date.available | 2021-08-31T11:29:40Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-02 | - |
dc.identifier.issn | 1742-4801 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/57833 | - |
dc.description.abstract | This study aimed to assess the efficacy of a new povidone-iodine (PVP-I) foam dressing (Betafoam) vs foam dressing (Medifoam) for the management of diabetic foot ulcers. This study was conducted between March 2016 and September 2017 at 10 sites in Korea. A total of 71 patients (aged >= 19 years) with type 1/2 diabetes and early-phase diabetic foot ulcers (Wagener classification grade 1/2) were randomised to treatment with PVP-I foam dressing or foam dressing for 8 weeks. Wound healing, wound infection, patient satisfaction, and adverse events (AEs) were assessed. The PVP-I foam and foam dressing groups were comparable in the proportion of patients with complete wound healing within 8 weeks (44.4% vs 42.3%, P = .9191), mean (+/- SD) number of days to complete healing (31.00 +/- 15.07 vs 33.27 +/- 12.60 days; P = .6541), and infection rates (11.1% vs 11.4%; P = 1.0000). Median satisfaction score (scored from 0 to 10) at the final visit was also comparable between groups (10 vs 9, P = .2889). There was no significant difference in AE incidence (27.8% vs 17.1%, P = .2836), and none of the reported AEs had a causal relationship with the dressings. The results of this study suggest that PVP-I foam dressing has wound-healing efficacy comparable with foam dressing, with no notable safety concerns. This study was funded by Mundipharma Korea Ltd and registered at (identifier NCT02732886). | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | RISK-FACTORS | - |
dc.title | Efficacy of a povidone-iodine foam dressing (Betafoam) on diabetic foot ulcer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Hak-Jun | - |
dc.identifier.doi | 10.1111/iwj.13236 | - |
dc.identifier.scopusid | 2-s2.0-85075710326 | - |
dc.identifier.wosid | 000498542800001 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL WOUND JOURNAL, v.17, no.1, pp.91 - 99 | - |
dc.relation.isPartOf | INTERNATIONAL WOUND JOURNAL | - |
dc.citation.title | INTERNATIONAL WOUND JOURNAL | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 91 | - |
dc.citation.endPage | 99 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordAuthor | Betafoam | - |
dc.subject.keywordAuthor | diabetic foot ulcer | - |
dc.subject.keywordAuthor | Medifoam | - |
dc.subject.keywordAuthor | povidone-iodine | - |
dc.subject.keywordAuthor | wound healing | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.